Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Ebola Sudan Virus Disease: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Ebola Sudan Virus Disease: 1 US clinical trial tracked, none currently recruiting.

Ebola Sudan Virus Disease is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Albert B. Sabin Vaccine Institute, running 1 of these trials.

Enrollment posture brief

Registry condition ebola-sudan-virus-disease

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Ebola Sudan Virus Diseas (th…0%
Open-enrollment share among volume-matched conditions near Ebola Sudan Virus Disease

Ebola Sudan Virus Disease has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ebola Sudan Virus Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ebola Sudan Virus Disease is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Ebola Sudan Virus Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

cAd3-Sudan Vaccine Biological
1 trials
Placebo Biological
1 trials

US sites by state

Facility locations filed on Ebola Sudan Virus Disease trials. A trial with sites in several states counts in each.

Texas 1 trials
Illinois 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ebola Sudan Virus Disease page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Ebola Sudan Virus Disease trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Albert B. Sabin Vaccine Institute sponsors the most Ebola Sudan Virus Disease trials on record, review their full trial history before evaluating a specific study. See Albert B. Sabin Vaccine Institute's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ebola Sudan Virus Disease condition card totals 1 registered trials; most-linked intervention cAd3-Sudan Vaccine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.